NPI: 1013905660 · KODIAK, AK 99615 · Critical Access Hospital · NPI assigned 10/07/2005
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY OF ENROLLMENTS) |
| NPI Enumeration Date | 10/07/2005 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,742 | $1.28M |
| 2019 | 10,194 | $1.51M |
| 2020 | 7,618 | $1.20M |
| 2021 | 8,444 | $1.41M |
| 2022 | 8,065 | $1.71M |
| 2023 | 8,408 | $2.06M |
| 2024 | 8,222 | $2.22M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,063 | 1,612 | $2.64M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 3,151 | 2,423 | $2.40M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 3,138 | 2,642 | $1.51M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 7,780 | 2,554 | $1.50M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3,167 | 1,071 | $553K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,851 | 1,619 | $484K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4,665 | 1,410 | $411K |
| 71046 | Radiologic examination, chest; 2 views | 1,336 | 1,244 | $331K |
| 80053 | Comprehensive metabolic panel | 5,260 | 4,044 | $251K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 942 | 799 | $160K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5,797 | 4,454 | $158K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 688 | 499 | $132K |
| J7050 | Infusion, normal saline solution, 250 cc | 1,505 | 879 | $104K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,251 | 381 | $97K |
| 96361 | Intravenous infusion, hydration; each additional hour | 509 | 406 | $73K |
| 96375 | Therapeutic injection; each additional sequential IV push | 538 | 418 | $69K |
| J7030 | Infusion, normal saline solution , 1000 cc | 640 | 461 | $66K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 57 | 50 | $54K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 349 | 225 | $38K |
| 81001 | 2,092 | 1,834 | $38K | |
| J3490 | Unclassified drugs | 720 | 415 | $29K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 1,922 | 914 | $28K |
| 84484 | 1,110 | 828 | $28K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 580 | 500 | $25K |
| 70450 | Computed tomography, head or brain; without contrast material | 29 | 25 | $19K |
| 86140 | 920 | 789 | $17K | |
| 83735 | 604 | 469 | $14K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 247 | 215 | $13K |
| 82077 | 519 | 440 | $12K | |
| 71045 | Radiologic examination, chest; single view | 63 | 53 | $12K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 585 | 491 | $12K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 174 | 166 | $10K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 42 | 37 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 155 | 110 | $9K |
| 80306 | 358 | 322 | $8K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 320 | 267 | $8K |
| 83690 | 454 | 384 | $7K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 570 | 494 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | 332 | 291 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 178 | 165 | $7K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 75 | 72 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 283 | 246 | $5K |
| A9150 | Non-prescription drugs | 1,009 | 645 | $5K |
| 97162 | 16 | 15 | $2K | |
| 81025 | 83 | 75 | $2K | |
| J2704 | Injection, propofol, 10 mg | 99 | 78 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 17 | 12 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 114 | 89 | $1K |
| 96376 | 15 | 12 | $1K | |
| 36415 | Collection of venous blood by venipuncture | 2,098 | 1,571 | $962.85 |
| 97535 | Self-care/home management training, each 15 minutes | 14 | 13 | $808.82 |
| 82962 | 35 | 25 | $730.01 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 30 | 30 | $345.24 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 45 | 42 | $333.42 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 12 | 12 | $236.99 |
| 80048 | Basic metabolic panel (calcium, ionized) | 26 | 26 | $140.24 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 15 | 12 | $106.74 |
| 85610 | 29 | 25 | $84.19 | |
| 83605 | 17 | 13 | $80.41 |